CY1116999T1 - COMPOSITION CONTAINING SHELLAC AND / OR HIS SALK AND STYLIC GLYCOLATE - Google Patents
COMPOSITION CONTAINING SHELLAC AND / OR HIS SALK AND STYLIC GLYCOLATEInfo
- Publication number
- CY1116999T1 CY1116999T1 CY20151101089T CY151101089T CY1116999T1 CY 1116999 T1 CY1116999 T1 CY 1116999T1 CY 20151101089 T CY20151101089 T CY 20151101089T CY 151101089 T CY151101089 T CY 151101089T CY 1116999 T1 CY1116999 T1 CY 1116999T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glycolate
- stylic
- salk
- composition containing
- containing shellac
- Prior art date
Links
Abstract
Αντικείμενο της παρούσας εφεύρεσης είναι μια σύνθεση shellac και/ή άλατος αυτού και αμυλούχου γλυκολικού νατρίου και ενός τουλάχιστον φυσιολογικώς αποδεκτού εκδόχου και μια διαδικασία για τη λήψη της.The object of the present invention is a composition of shellac and / or a salt thereof and starch sodium glycolate and at least one physiologically acceptable excipient and a process for obtaining it.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36772010P | 2010-07-26 | 2010-07-26 | |
ITMI2010A001386A IT1401146B1 (en) | 2010-07-27 | 2010-07-27 | COMPOSITION INCLUDING SHELLAC AND / OR HIS SALT AND GLYCOLATED SODIUM STARCH |
EP11738822.3A EP2598122B1 (en) | 2010-07-26 | 2011-06-30 | Composition comprising shellac and/or a salt thereof and sodium starch glycolate |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1116999T1 true CY1116999T1 (en) | 2017-04-05 |
Family
ID=56418128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151101089T CY1116999T1 (en) | 2010-07-26 | 2015-11-30 | COMPOSITION CONTAINING SHELLAC AND / OR HIS SALK AND STYLIC GLYCOLATE |
Country Status (3)
Country | Link |
---|---|
CY (1) | CY1116999T1 (en) |
IL (1) | IL224086A (en) |
ZA (1) | ZA201300132B (en) |
-
2012
- 2012-12-31 IL IL224086A patent/IL224086A/en active IP Right Grant
-
2013
- 2013-01-07 ZA ZA2013/00132A patent/ZA201300132B/en unknown
-
2015
- 2015-11-30 CY CY20151101089T patent/CY1116999T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL224086A (en) | 2017-06-29 |
ZA201300132B (en) | 2013-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121460T1 (en) | CONFIGURATION OF THE SIGNAL TRANSFERER AND THE EXPRESSION EXPRESSOR OF TRANSFER 3 (STAT3) | |
CY1120318T1 (en) | Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients | |
CY1118004T1 (en) | SUSPENSIONS CDK | |
CY1119199T1 (en) | CDC7 Suspensions | |
ZA201401815B (en) | Tibial orthopaedic surgical instruments for setting offset | |
GB2552855B (en) | Surgical instrument engagement detection | |
CY1119422T1 (en) | BETOULINE PRODUCERS | |
CY1118129T1 (en) | 5-ALKYNYL-PYRIMIDINES | |
CY1118695T1 (en) | SUSPENSIONS OF STONES | |
CY1118143T1 (en) | Heterocyclic compounds useful as PDK1 inhibitors | |
CR20130045A (en) | THERAPEUTIC COMPOUNDS | |
BR112013023604A2 (en) | fixation surgical instruments | |
EA201171367A1 (en) | VINYLINDASOLYL COMPOUNDS | |
DK2319433T3 (en) | Orthopedic Surgical Instrument | |
ZA201401892B (en) | Femoral orthopaedic instrument assembly for setting offset | |
MA34057B1 (en) | Formulations and methods for the diagnosis and treatment of tumor | |
CY1122358T1 (en) | C-TERMINAL HSP90 INHIBITORS | |
GB202114497D0 (en) | Bone resection instrument | |
EP3648693A4 (en) | Medical instrument forin vivo | |
PH12017501955A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease | |
IT1401767B1 (en) | FOOTWEAR FOR THE CORRECTION OF ANATOMICAL DEFECTS OR OF WALKING. | |
CY1113338T1 (en) | NEW METHOD FOR COMPOSITION OF IBABRADIN AND SALT ADDITION | |
CY1121709T1 (en) | TETRAHYDROPYRROLE[3,4-D][1,3]THIAZINE DERIVATIVE AS A BACE INHIBITOR | |
CY1116999T1 (en) | COMPOSITION CONTAINING SHELLAC AND / OR HIS SALK AND STYLIC GLYCOLATE | |
MX336929B (en) | Composition comprising shellac and/or a salt thereof and sodium starch glycolate. |